(Q37085136)

18 August 2017

1 reference

title

Tumour immunity: effector response to tumour and role of the microenvironment (English)

1 reference

18 August 2017

1

1 reference

18 August 2017

3

A Karolina Palucka

1 reference

18 August 2017

4

Francesco M Marincola

1 reference

18 August 2017

Pedro Romero

2

1 reference

PubMed ID

18275997

18 August 2017

language of work or name

English

0 references

publication date

13 February 2008

1 reference

18 August 2017

1 reference

18 August 2017

371

1 reference

18 August 2017

771-783

1 reference

18 August 2017

9614

1 reference

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

18 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

New paths in human cancer serology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Tumors as elusive targets of T-cell-based active immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Effective immunotherapy against cancer: a question of overcoming immune suppression and immune escape?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Breaking tolerance in cancer immunotherapy: time to ACT.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Immune regulation and colitis: suppression of acute inflammation allows the development of chronic inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Local and systemic inflammation in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Adaptive immune responses in acute and chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Gene-expression profiling of the response of peripheral blood mononuclear cells and melanoma metastases to systemic IL-2 administration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Inflammation and cancer: back to Virchow?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Spontaneous regression of metastatic renal cancer. Case report and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Spontaneous regression of melanoma may offer insight into cancer immunology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Inflammation by remote control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Differential Anti-MART-1/MelanA CTL Activity in Peripheral Blood of HLA-A2 Melanoma Patients in Comparison to Healthy Donors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Cancer incidence after immunosuppressive treatment following kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Incidence of cancer after immunosuppressive treatment for heart transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Incidence and risk factors for cancer after liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Secondary malignancies after hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

The three Es of cancer immunoediting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Smoldering and polarized inflammation in the initiation and promotion of malignant disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

NF-kappaB: linking inflammation and immunity to cancer development and progression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Progress and controversies in developing cancer vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Update on the role of interleukin 2 and other cytokines in the treatment of patients with stage IV renal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Trastuzumab in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Bacteria and cancer: cause, coincidence or cure? A review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

IL-1 is required for tumor invasiveness and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

COX-2 inhibition and colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

A Paracrine Loop between Tumor Cells and Macrophages Is Required for Tumor Cell Migration in Mammary Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Alternative activation of macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

The chemokine system in diverse forms of macrophage activation and polarization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Macrophage polarization comes of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Blocking IL-1 in systemic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Alternatively activated macrophages during parasite infections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Fibrotic disease and the T(H)1/T(H)2 paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Regulation of the chemokine receptor CXCR4 by hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Regulation of immune responses by L-arginine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

IL-6 switches the differentiation of monocytes from dendritic cells to macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

TNF skews monocyte differentiation from macrophages to dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

The many faces of macrophage activation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Tumor inflammatory angiogenesis and its chemoprevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

SHIP represses the generation of alternatively activated macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Targeting myelomonocytic cells to revert inflammation-dependent cancer promotion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Mouse and human dendritic cell subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Cell biology of antigen processing in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Dendritic-cell control of pathogen-driven T-cell polarization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Tolerogenic dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Mechanisms and functional significance of tumour-induced dendritic-cell defects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Inflammation and necrosis promote tumour growth

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Differentiation of T regulatory cells by immature dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Levels of complexity in pathogen recognition by C-type lectins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Recognition of tumor glycans by antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

MUC1 immunobiology: from discovery to clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Is it a DC, is it an NK? No, it's an IKDC

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

A novel dendritic cell subset involved in tumor immunosurveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Cancer immunotherapy: breaking the barriers to harvest the crop

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Progress on new vaccine strategies against chronic viral infections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Rational approaches to human cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Dendritic cells as therapeutic vaccines against cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

The use of dendritic cells in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Cross-presentation, dendritic cells, tolerance and immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

MHC multimer technology: current status and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Thymic selection generates a large T cell pool recognizing a self-peptide in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Degeneracy of antigen recognition as the molecular basis for the high frequency of naive A2/Melan-a peptide multimer(+) CD8(+) T cells in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Vaccination of melanoma patients with an allogeneic, genetically modified interleukin 2-producing melanoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Ex vivo analysis of human antigen-specific CD8+ T-cell responses: quality assessment of fluorescent HLA-A2 multimer and interferon-gamma ELISPOT assays for patient immune monitoring.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Definition of an immunologic response using the major histocompatibility complex tetramer and enzyme-linked immunospot assays.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

High frequencies of functionally impaired cytokeratin 18-specific CD8+ T cells in healthy HLA-A2+ donors.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

High frequency of functionally active Melan-a-specific T cells in a patient with progressive immunoproteasome-deficient melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Quiescent phenotype of tumor-specific CD8+ T cells following immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Frequency of MART-1/MelanA and gp100/PMel17-specific T cells in tumor metastases and cultured tumor-infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Detection of Wilms' tumor antigen--specific CTL in tumor-draining lymph nodes of patients with early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

IL-12 reverses anergy to T cell receptor triggering in human lung tumor-associated memory T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Tumor progression despite massive influx of activated CD8(+) T cells in a patient with malignant melanoma ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Immune responses to p53 in patients with cancer: enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Lessons from the study of T-cell differentiation in persistent human virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Restoring function in exhausted CD8 T cells during chronic viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Immunosuppressive networks in the tumour environment and their therapeutic relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

HSP70 vaccine in combination with gene therapy with plasmid DNA encoding sPD-1 overcomes immune resistance and suppresses the progression of pulmonary metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Cycloxygenase-2 inhibition augments the efficacy of a cancer vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Immunology of hepatitis B virus and hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Introduction to the series. Danger model of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Is cancer dangerous to the immune system?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Molecular and functional profiling of memory CD8 T cell differentiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Immune surveillance against a solid tumor fails because of immunological ignorance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Melanoma-restricted genes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

A balanced review of the status T cell-based therapy against cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Active-specific immunization against melanoma: is the problem at the receiving end?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Expansion of tumor-T cell pairs from fine needle aspirates of melanoma metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Real-time quantitative polymerase chain reaction assessment of immune reactivity in melanoma patients after tumor peptide vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

1 reference

7 January 2021

Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Imiquimod: a cytokine inducer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Toll-like receptor control of the adaptive immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960241-X

7 January 2021

10.1016/S0140-6736(08)60241-X

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18275997